Biotechnology | Markets Herald

May 7, 2024

Nuvectis Pharma Reports Q1 Results, Expects Several Clinical Updates in H2 2024

Nuvectis Chairman & CEO Ron Bentsur: “2024 is shaping up to be a potentially transformational year for Nuvectis with several clinical data updates expected in the second half of the year.”

Dr. Lin visits Beauty-Stem's Grand Opening in LA. CD34 Stem cell. © Power-Stem Biomedical

April 13, 2024

Beauty-Stem Biomedical Unveils CD34 Stem Cell Immunology at Grand Opening Event

February 6, 2024

Maintaining High-Level Transparency in Health Supplements: Here’s How Phoenix Creative Nutraceuticals is Doing It With Glucoferrin

August 16, 2023

Innocan Pharma’s Breakthrough: Diabetic Foot Relief Treatment Demonstrates Remarkable Efficacy

Unlocking Market Potential: Innocan Pharma's Breakthrough Cream Shows Promise in Diabetic Foot Care

July 24, 2023

Cell Culture Media Market Worth $13.0 Billion

May 1, 2023

Alliospharma Women’s Health: The Only Serious Alternative to Antibiotics in Women’s Health!

April 22, 2023

Innocan Pharma Reports +1226% in Revenue during 2022, Plans to Reach Pre-IND Meeting by EOY

April 19, 2023

Steakholder Foods Makes History: Israeli Prime Minister Tastes Cultivated Foods and Tours Revolutionary 3D Bio-Printing Technology

January 24, 2023

Welzo Announces Launch of AI-Powered Home Blood Testing Service

January 13, 2023

How Biomimicry Helps to Innovate Sustainable Solutions

October 1, 2022

Biome Makers and Syngenta Crop Protection Team Up to Address Soil Health in Agriculture

September 13, 2022

Nutraceutical Market Highlight: SMK Global – The Art of Modern Contract Manufacturing in the U.S.

July 26, 2022

Biopharmaceutical Sector to Remain Key Lyophilization End User, Food & Beverage Sector to Follow Suit

Astellas Plans to Create an Integrated Biotechnology Campus in South San Francisco

July 21, 2022

Astellas Pharma Plans to Create an Integrated Biotechnology Campus in South San Francisco

July 17, 2022

Texas Biomed Tapped for National ‘Dream Team’ Developing Antivirals Against COVID-19 and Other Threats

June 15, 2022

The Licensing of Academic Patents Contributed Up to $1.9 Trillion to the US Economy, Supported up to 6.5M Jobs in the last 25 Years

March 22, 2022

Joel Drai and MEGA BIOPHARMA: Mother-of-Pearl’s New Vision of Medical Treatment

March 14, 2022

OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico

February 21, 2022

BC Platforms Adds Japan’s Mitsubishi Space Software to its Global Data Network

Dr. Dimitris Panagopoulos, the New Ηead of the Scientific Council of IRCBB

January 29, 2022

Dr. Dimitris Panagopoulos, the New Head of the Scientific Council of IRCBB

January 7, 2022

GG Omicron and Delta PCR Testing for Clinical Triage of COVID Patients

January 6, 2022

OcyonBio Appoints Robert Salcedo as Chief Executive Officer

OcyonBio CDMO welcomes cell and gene therapy expert Robert Salcedo who brings over 20 years of expertise in the areas of CMC, operations, and supply chain management and has served in multi-billion-dollar companies operating in biotech, vaccines, and pharmaceutical markets.